Jaypirca
Term · Oncology and biomedicine · MLC-T-ONC-004575
A drug used to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or mantle cell lymphoma that was treated with at least two other types of therapy, including a BTK inhibitor. It is also being studied in the treatment of other types of cancer. Jaypirca blocks a protein called BTK, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called pirtobrutinib.
| Identifier | MLC-T-ONC-004575 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | pirtobrutinib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004575",
"term": "Jaypirca",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or mantle cell lymphoma that was treated with at least two other types of therapy, including a BTK inhibitor. It is also being studied in the treatment of other types of cancer. Jaypirca blocks a protein called BTK, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called pirtobrutinib.",
"synonyms": [
"pirtobrutinib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/jaypirca/"
}
Record 9,684 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.